Mild essential hypertension: benefit of treatment: discussion.
W M Smith
https://pubmed.ncbi.nlm.nih.gov/360933Completed
Phase 3
Age: 21Years - 55Years
All Genders
ID00000484
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2013-11-26
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine whether the long-term treatment of essential hypertension without significant target organ disease materially influenced mortality and/or cardiovascular renal morbidity.
CONDITIONS
Official Title
Treatment of Hypertension
Who Can Participate
Age: 21Years - 55Years
All Genders
Eligibility Criteria
You may qualify if you...
Men and women, ages 21-55. Mild essential hypertension (diastolic blood pressure over 90 mm Hg.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here